Panzyga (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a unknown/intravenous solution for intravenous use. It replaces deficient antibodies and is used to treat primary immunodeficiency disorders and certain immune‑mediated conditions in both children and adults.

GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Panzyga is an immunoglobulin therapy that acts on the humoral immune system to provide passive immunity. - Primary immunodeficiency diseases (PID): Improves the ability to fight the infection by supplying functional antibodies. - Secondary immune deficiencies caused by chronic lymph leukemia or chemotherapy t  .... -  .... etc… - .... .... .... ... ... ... .... ... ...

Common  ....

{}

{}